Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial

NCT00161070 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT00161070
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00161070 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ESPRIT: European/Australasian Stroke Prevention in Reversible Ischaemia Trial
Lead sponsor
UMC Utrecht
Phase
Phase 4
Overall status
Completed
Start date
July 31, 1997
Completion date
December 31, 2006
Enrollment
4,500
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arteriosclerosis, brain ischemia, transient ischemic attack